Ipsen, S.A. insider trades: Rhythm Pharmaceuticals (RYTM) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ipsen, S.A. reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 10, 2017 | RYTM | ↑ Buy | 20,000 | $17.00 | $340K | The owner of record of the securities is | Oct 10, 2017 (0d) |
| Jul 22, 2008 | TRCA | ↑ Buy | 410,831 | $8.92 | $3.7M | Direct | Jul 23, 2008 (1d) |
| Aug 30, 2007 | TRCA | ↑ Buy | 519,101 | $5.63 | $2.9M | Direct | Aug 1, 2007 (0d) |
| Oct 13, 2006 | TRCA | ↑ Buy | 12,527,245 | $6.17 | $77.3M | Direct | Oct 18, 2006 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RYTM insiders
Open-market trades in the last 12 months
About Ipsen, S.A.'s insider trades
Ipsen, S.A. is a 10% owner of Rhythm Pharmaceuticals (RYTM). Since Oct 13, 2006, it has reported 4 open-market purchases worth $84.2M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RYTM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.